Wentao Mu

Jilin University — China

Medicine · Health Sciences

11h-index309citations18works13.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies(11), MicroRNA in disease regulation(4), Cancer-related molecular mechanisms research(4), Extracellular vesicles in disease(3), Liver Disease Diagnosis and Treatment(2)

Publications18 total

Cisplatin-induced disruption of mitochondrial divisome leads to enhanced cisplatin resistance in cholangiocarcinoma
Journal of Hepatology·2025· 8 cited
Endoplasmic reticulum stress and quality control in relation to cisplatin resistance in tumor cells
Frontiers in Pharmacology·2024· 19 citedOpen Access
Exploring the effects of epigallocatechin gallate on lipid metabolism in the rat steatotic liver during normothermic machine perfusion: Insights from lipidomics and RNA sequencing
European Journal of Pharmacology·2023· 4 cited
Quenching thirst with poison? Paradoxical effect of anticancer drugs
Pharmacological Research·2023· 2 citedOpen Access
From clinical variables to multiomics analysis: a margin morphology-based gross classification system for hepatocellular carcinoma stratification
Gut·2023· 14 citedOpen Access
Associations of cholecystectomy with the risk of colorectal cancer: a Mendelian randomization study
Chinese Medical Journal·2023· 21 citedOpen Access
Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
Hepatology International·2022· 35 cited
Examination on the risk factors of cholangiocarcinoma: A Mendelian randomization study
Frontiers in Pharmacology·2022· 12 citedOpen Access
BMI1 promotes cholangiocarcinoma progression and correlates with antitumor immunity in an exosome-dependent manner
Cellular and Molecular Life Sciences·2022· 42 citedOpen Access
BMI1 Promotes Cholangiocarcinoma Progression and Correlates with Antitumor Immunity in An Exosome-Dependent Manner
2022Open Access
Bmi1 Promotes Cholangiocarcinoma Progression And Correlates With Antitumor Immunity In An Exosome-Dependent Manner
Research Square (Research Square)·2022· 1 citedOpen Access
Aldehyde dehydrogenase 3B2 promotes the proliferation and invasion of cholangiocarcinoma by increasing Integrin Beta 1 expression
Cell Death and Disease·2021· 46 citedOpen Access
Long Noncoding RNA SNHG1 Regulates LMNB2 Expression by Sponging miR-326 and Promotes Cancer Growth in Hepatocellular Carcinoma
Frontiers in Oncology·2021· 22 citedOpen Access
The Smad4-MYO18A-PP1A complex regulates β-catenin phosphorylation and pemigatinib resistance by inhibiting PAK1 in cholangiocarcinoma
Cell Death and Differentiation·2021· 41 citedOpen Access
Recent Advances in the Mechanism Research and Clinical Treatment of Anti-Angiogenesis in Biliary Tract Cancer
Frontiers in Oncology·2021· 12 citedOpen Access
Case Report: Incidentally Discovered a Rare Cystic Lesion of Liver: Multicystic Biliary Hamartoma
Pathology & Oncology Research·2021· 9 citedOpen Access
Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma
International Journal of Oncology·2020· 16 citedOpen Access
Background Suppression Based on Improved Top-Hat and Saliency Map Filtering for Infrared Ship Detection
2017· 5 cited

Frequent Co-authors

Guoyue Lv(9), Kaiyuan Chai(7), Kangshuai Li(6), Zengli Liu(6), Jialiang Liu(6), Anda Shi(6), Tianli Chen(6), Zongli Zhang(6), Zhongqi Fan(5), Wei Qiu(5), Guangyi Wang(5), Xingyong Li(4), Yannan Cao(4), Jianpeng Zhou(4), Chuanlei Wang(4), Yunfei Xu(3), Chang Pan(3), Lijie Zheng(3), Yue Wang(3), Lanlan Chen(3)